PARP (Poly ADP‐Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer

Overview of attention for article published in Cochrane database of systematic reviews, April 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

news: 1 news outlet
twitter: 24 X users

facebook: 2 Facebook pages

Citations

dimensions_citation: 33 Dimensions

Readers on

mendeley: 158 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 2 public wall posts from 2 users.

Wiley Clinical Health, 06 May 2021

Read this new The Cochrane Libraryy Cochrane Breast Cancer systematic review on PARP inhibitors for locally advanced or…

Cochrane Nigeria, 01 May 2021

In people with locally advanced or metastatic HER2-negative, BRCA germline mutated breast cancer, PARP inhibitors offer an…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.